John Moriarty Email & Phone Number

San Diego, California, United States

San Diego, California, United States

Reported to the company’s Founder and Chief Executive Officer with broad responsibility serving on the Executive Leadership Team, scaled the company for growth and value creation, executed business development strategies and transactions as a newly commercial biotech company, led Mirati’s global legal team, and enhanced corporate governance. As a key member of the deal team, led the company's acquisition by Bristol Myers Squibb for ~$5.8B in January 2024.

San Francisco, California, United States

Reported to the Chief Executive Officer, and while serving on the Executive Committee, built from scratch Olema’s legal, compliance, and governance functions and scaled the company from a private oncology startup to a public development-stage company with a promising oncology pipeline. Joined Olema as its ninth employee in September 2020 to guide the company through its $85M Series C crossover financing round and take the company public in its follow-on $240M 2020 IPO.

South San Francisco

Reported to the Chief Executive Officer, and as a member of the Executive Committee, led all legal, governance, and compliance initiatives, including playing a key role in leading strategic transactions, market entry, and international operations for a commercial stage biotech company. As a key member of the deal team, led the company's acquisition by Alexion Pharmaceuticals in 2020 for $1.4B.

Greater New York City Area

As General Counsel and Executive Steering Committee member for an S&P 500 global company, advised the CEO and Board on all strategic and governance matters. Responsible for all global legal matters across 50 + countries, including corporate strategy/transactional matters, securities, and SEC disclosure issues, litigation, compliance, regulatory interactions, employment matters, and intellectual property. Additional responsibilities included leading Alexion’s Global Government Affairs and Pricing and Reimbursement teams (2012-2015), based in Washington, DC, and Brussels, Belgium, as well as Alexion’s Corporate Communications and Corporate Affairs group, based globally (2012-2017). During tenure, we grew market capitalization from $20B in 2012 to $45B in 2015.

Greater New York City Area

San Francisco, Ca And Dublin, Ireland

As General Counsel, reporting to the Chief Executive Officer, and as a member of the Executive Management Team, built and led the 50-person global law department. Partnered with Board and executive leadership in corporate strategy/transactional matters, securities issues, executive compensation, employment matters, and intellectual property.

Executive Director and Associate General CounselPharmaceutical Litigation, Investigations, General Business Counseling, Drug Development and Commercialization Law

Washington, District Of Columbia, United States

Senior Associate -- Health Care Litigation and Government Enforcement Groups

Richmond, Virginia, United States

Health Care Fraud Enforcement -- Civil and Criminal

Doctor Of Law - Jd, Law

Cum Laude

Bachelor Of Arts - Ba

With Distinction